Bispecific anti PD1-anti TIM3 antibodies
US-12577306-B2 · Mar 17, 2026 · US
This page is not indexed by search engines while we improve data quality.
Throsby Mark patents
Throsby Mark is listed as an inventor on 78 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Throsby Mark |
| Total patents | 78 |
| First publication | Aug 30, 2016 |
| Latest publication | Mar 17, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
TGF-beta-RII binding proteins
US-12570747-B2 · Mar 10, 2026 · US
Bispecific antibody
US-2025368736-A1 · Dec 4, 2025 · US
Tgf-beta-rii binding proteins
US-2025270331-A1 · Aug 28, 2025 · US
Generation of binding molecules
US-2025230579-A1 · Jul 17, 2025 · US
Bispecific antibody
US-12325746-B2 · Jun 10, 2025 · US
Generation of binding molecules
US-12291798-B2 · May 6, 2025 · US
ERBB-2 and ERBB-3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene
US-12247078-B2 · Mar 11, 2025 · US
Antibody that binds ErbB-2 and ErbB-3
US-12139548-B2 · Nov 12, 2024 · US
Binding molecules that inhibit cancer growth
US-2024343824-A1 · Oct 17, 2024 · US
Recent patents
Latest publications not already listed above.
Bispecific antibody
US-12091461-B2 · Sep 17, 2024 · US
Bispecific antibody
US-2024287187-A1 · Aug 29, 2024 · US
Binding molecules that bind cd137 and pd-l1
US-2024209105-A1 · Jun 27, 2024 · US
Erbb-2 and erbb3 binding bispecific antibodies for use in the treatment of cells that have an nrg1 fusion gene
US-2024199747-A1 · Jun 20, 2024 · US
Erbb-2 and erbb-3 binding bispecific antibodies for use in the treatment of cells that have an nrg1 fusion gene
US-2024182587-A1 · Jun 6, 2024 · US
Antibodies that bind egfr and cmet
US-2024174756-A1 · May 30, 2024 · US
Antibody that binds erbb-2 and erbb-3
US-2024158532-A1 · May 16, 2024 · US
Antibody that binds erbb-2 and erbb-3
US-2024158531-A1 · May 16, 2024 · US
Antibody producing non-human animals
US-2024156072-A1 · May 16, 2024 · US
Binding molecules that inhibit cancer growth
US-11939394-B2 · Mar 26, 2024 · US
Antibodies that bind egfr and erbb3
US-2024052043-A1 · Feb 15, 2024 · US
Binding molecules that modulate a biological activity expressed by a cell
US-2024034794-A1 · Feb 1, 2024 · US
Antibody producing non-human animals
US-2024023527-A1 · Jan 25, 2024 · US
Antibodies that modulate a biological activity expressed by a cell
US-2023406932-A1 · Dec 21, 2023 · US
Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor
US-11820825-B2 · Nov 21, 2023 · US
Bispecific anti pd1-anti tim3 antibodies
US-2023357407-A1 · Nov 9, 2023 · US
Antibody producing non-human animals
US-11785924-B2 · Oct 17, 2023 · US
ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene
US-11780925-B2 · Oct 10, 2023 · US
Antibodies that bind EGFR and cMET
US-11773170-B2 · Oct 3, 2023 · US
Bispecific anti PD1-anti TIM3 antibodies
US-11753470-B2 · Sep 12, 2023 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Merus Nv | 66 |
| Ono Pharmaceutical Co | 9 |
| Merus B V | 4 |
| Crucell Holland Bv | 2 |
| Janssen Vaccines & Prevention Bv | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/31 | 68 |
| C07K2317/76 | 58 |
| A61K2039/505 | 49 |
| C07K16/2863 | 46 |
| C07K16/32 | 44 |